Women with breast cancer who were also carriers of the BRCA1 or BRCA2 mutation and received textured breast implants as part ...

A study shows that women with BRCA1 or BRCA2 mutations who have textured breast implants are at a 16-fold higher risk of ...

The phase 1b trial’s primary endpoints are the occurrence of adverse events, including dose-limiting toxicities, and the ...

Research shows that the drug tazemetostat – which is already approved for use in patients with one type of B-cell lymphoma – ...

A woman who was diagnosed with Hodgkin lymphoma, an uncommon type of blood cancer, has shared the symptoms she had in the ...

CAR-T therapy, which has been available since last year through a collaboration between the Red Cross and Auxilio Mutuo ...